Stryker Snapshot

Click here to go back to main page.

Stryker Corporation
Brief Description Stryker's surgical products include such instruments as drills, saws, and even cement mixers. The company's Reconstructive division markets artificial hip and knee joints, trauma implants, bone cement, and other orthopedic supplies. The MedSurg Equipment segment houses microsurgery instruments, endoscopy equipment, and communications and patient handling tools. Stryker's Neurotechnology and Spine unit provides rods, screws, and artificial discs for spinal surgeries, as well as coils and stents for cerebral vascular procedures. The firm's products are marketed globally to hospitals, doctors, and other health care facilities via direct sales personnel and distributors.
Revenues 2008: 6.72 billion USD
2009: 6.72 billion USD
2010: 7.32 billion USD
Net profit (2010) 1.27 billion USD
R&D expenses 2008: 367.8 million USD (5.5% of revenues)
2009: 336.2 million USD (5.0% of revenues)
2010: 393.9 million USD (5.4% of revenues)
Number of employees 20,036
Year Established 1938
Headquarters 2825 Airview Blvd. Kalamazoo, MI 49002-1802, United States
Key People Stephen MacMillan (Chairman & CEO)
Curt Hartman (CFO)
Segmental revenue breakdown (2010) Orthopedic implants: 59%
MedSurg equipment: 41%
Geographical revenue breakdown (2010) US: 65%%
Rest of world: 35%